Home / Tag Archives: biosimilar insulin

Tag Archives: biosimilar insulin

The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care

Insulin pens beside an FDA symbol and prescription form representing interchangeable insulin biosimilars and pharmacy-level insulin switching in diabetes care.

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Read More »